Moderately large doses of intravenous vitamin C can quickly and significantly improve the quality of life, and reduce pain, in terminal cancer patients, according to a study done by Korean physicians. IV vitamin C is far more potent than oral forms in cancer treatment. In a study of 39 terminal cancer patients, quality of life scores jumped from 36 to 55 (a 53% improvement) on a standardized questionnaire. The patients had significant improvements in physical, emotional, and cognitive function. They also had better appetites and decreases in fatigue, pain, nausea, and vomiting.
In another study assessment performed by the NIH (National Institutes of Health), they found 3 well-documented cases of advanced cancers, where patients had unexpectedly long survival times after receiving high-dose intravenous vitamin C therapy.
http://www.koreamed.org/SearchBasic.php?DT=1&RID=345978
http://www.cmaj.ca/cgi/content/abstract/174/7/937
Adapted from The Nutrition Reporter, June 2007, Vol 18 No 6
by Jack Challem
No comments:
Post a Comment